Tech Company Financing Transactions
Tigercat Pharma Funding Round
On 9/30/2013, Tigercat Pharma announced funding from Remeditex Ventures.
Transaction Overview
Company Name
Announced On
9/30/2013
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
400 Oyster Point Blvd. 202
South San Francisco, CA 94080
USA
South San Francisco, CA 94080
USA
Phone
Email Address
Not Recorded
Overview
Tigercat Pharma, Inc. offers drug development services. The company hold the ownership of the VPD-737 development program to treat chronic pruritus.The company was founded in 2011.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
James Larrick
Browse more venture capital transactions:
Prev: 9/30/2013: Cidara Therapeutics venture capital transaction
Next: 9/30/2013: ActivAided Orthotics venture capital transaction
Share this article
About Database of VC Transactions
We do our best to document every notable VC transaction. VC investment data records reported here are derived from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs